Global News

Catalent to acquire Pharmatek

Thursday, September 15, 2016

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced an agreement for Catalent, through its wholly owned subsidiary, Catalent Pharma Solutions, to acquire Pharmatek Laboratories, a West Coast, U.S.-based specialist in drug development and clinical manufacturing.

[Read More]

Allergan to acquire Vitae Pharmaceuticals for $639M

Thursday, September 15, 2016

Allergan, a global pharmaceutical company, and Vitae Pharmaceuticals, a clinical-stage biotechnology company, have entered into a definitive agreement under which Allergan will acquire Vitae for $21.00 per share, in cash, for a total transaction value of approximately $639 million. The Boards of Directors of both companies have unanimously approved the transaction.

[Read More]

Exco InTouch appoints Steve Powell as chief operating officer

Wednesday, September 14, 2016

Exco InTouch, a provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, has appointed Steve Powell as the company’s chief operating officer and president. In this newly created position, Powell will be responsible for all aspects of Exco InTouch’s operational delivery including services and technology.  

[Read More]

SCRS, NAVREF partner

Wednesday, September 14, 2016

The Society for Clinical Research Sites (SCRS) and the National Association of Veterans’ Research and Education Foundations (NAVREF) have announced an alliance between the two organizations. This relationship will provide SCRS membership, mentoring and training, and other elements to NAVRAF members. NAVREF is the nonprofit research and education association with 80 member sites affiliated with Department of Veterans Affairs medical centers.

[Read More]

Sanofi, Verily Life Sciences launch Onduo for diabetes management platform

Wednesday, September 14, 2016

Sanofi and Verily Life Sciences, (formerly Google Life Sciences), an Alphabet company, have announced the launch of Onduo, a joint venture created through Sanofi and Verily’s diabetes-focused collaboration. The joint venture is based in Kendall Square in Cambridge. Onduo’s mission is to help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management.

[Read More]

Janssen completes WHO submission for EUAL for Ebola vaccine regimen

Wednesday, September 14, 2016

Bavarian Nordic has announced that Janssen Vaccines & Prevention has completed a submission to the World Health Organization (WHO) for Emergency Use Assessment and Listing (EUAL) for its investigational preventive Ebola prime-boost vaccine regimen, which includes Bavarian Nordic’s MVA-BN Filo vaccine. The EUAL is a special procedure that can be implemented when there is an outbreak of a disease with high rates of morbidity or mortality and a lack of treatment or prevention options.

[Read More]

Horizon Pharma to acquire Raptor Pharmaceutical

Wednesday, September 14, 2016

Horizon Pharma and Raptor Pharmaceutical have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued and outstanding shares of Raptor Pharmaceutical Corp. common stock for $9.00 per share in cash, for an implied fully diluted equity value of approximately $800 million. The transaction is expected to close in the fourth quarter of 2016.

[Read More]

Pfizer appoints chief scientific officer for Neuroscience Research

Wednesday, September 14, 2016

Pfizer has announced that Dr. Ole Isacson, a world-renowned scientist and thought leader in neurology, will become chief scientific officer of the Neuroscience Research Unit and senior vice president, effective September 16. Dr. Isacson is a professor of Neurology at Harvard Medical School, and will continue to serve in an educational role. He is also a founding director of the Neuroregeneration Institute at McLean Hospital. Dr. Isacson will report directly to Mikael Dolsten, president of Worldwide Research and Development.

[Read More]